Dr. Julia Ljubimova to speak on Nano Therapeutics at TechConnect World Nano Conference18 July 2012
TechConnect World Nanotech Conference was held at Santa Clara California during June 18-21, 2012 and Dr. Julia Ljubimova was invited to the conference as speaker. Dr. Julia, Chief Scientific Officer and President, Arrogene Inc. discussed on the latest developments on nano therapeutics.
The TechConnect conference is one of the largest conference that provides opportunity to various researchers, developers, innovators, users and marketers to interact with each other and at the same time it is one of the best multi-disciplinary and multi sector conference. Dr. Julia is one among the best speakers that was invited to deliberate some of the latest developments in various disciplines.
Some of the innovative technologies has already been developed at Cedars – Sinai Medical Centre and are being under exclusive license by Arrogene. The company has done marvelous job by developing the new generation nanomedicine that are capable of targeting cancer cells and thus further stopping the growth of cancer cells and these technologies has discussed in details at the conference.
It will look like this: Dr. Julia Ljubimova to speak on Nano Therapeutics at TechConnect World Nano Conference